MEDICURE
Medicure

Licensing & Commercialization Opportunities
PARTNERING OPPORTUNITIES
Medicure is seeking a partner with an established cardiovascular franchise to support ongoing worldwide clinical development programs, to assist with the commercialization of MC-1 and other pipeline compounds, and to collaborate on drug development and drug discovery programs and activities. Medicure continues to hold discussions with potential partners with the intent to secure a formal partnership agreement.

The Company's business strategy and goal is to create optimal value for shareholders, by establishing partnerships that provide a strong marketing presence and use proven development and commercialization expertise.

Click here for the Non-Confidential Anti-thrombotic program licensing package.

IN-LICENSING
Medicure maintains an interest in in-licensing and co-promoting cardiovascular brands and technologies. Medicure will identify and expand its portfolio of products to complement and broaden its focus in cardiovascular disease and to build on its existing expertise in cardiovascular biology, medicinal chemistry and clinical development.

Products In Development AGGRASTAT

MC-1 Chronic

MC-1 Acute

Licensing Opportunities

Antithrombotic Discovery Program



Legal - Privacy
For more information please email us: info@medicure.com